stemcardiocell.com
CardioCell : Breakthrough Cardiovascular TherapyUsing Stemedica’s patented itMSCs, CardioCell explores therapies for acute myocardial infarction, chronic heart failure and peripheral artery disease.
http://www.stemcardiocell.com/
Using Stemedica’s patented itMSCs, CardioCell explores therapies for acute myocardial infarction, chronic heart failure and peripheral artery disease.
http://www.stemcardiocell.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
4.2 seconds
16x16
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
BUY YOUR DOMAIN
10
YEARS
6
MONTHS
9
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
14
SSL
EXTERNAL LINKS
5
SITE IP
184.168.47.225
LOAD TIME
4.198 sec
SCORE
6.2
CardioCell : Breakthrough Cardiovascular Therapy | stemcardiocell.com Reviews
https://stemcardiocell.com
Using Stemedica’s patented itMSCs, CardioCell explores therapies for acute myocardial infarction, chronic heart failure and peripheral artery disease.
stemcardiocell.com
CardioCell : Media Coverage
http://stemcardiocell.com/category/news/media-coverage
Exclusive Stem Cell License. Tuesday, August 30, 2016. CardioCell reports Phase IIa heart failure data. Data presented at the European Society of Cardiology meeting in Rome showed that a single intravenous administration of ischemic-tolerant mesenchymal stem cells ( itMSCs. From CardioCell LLC met the primary safety endpoint and several secondary efficacy endpoints in a single-blind Phase IIa trial to treat chronic heart failure (CHF) in patients with non-ischemic cardiomyopathy. READ FULL ARTICLE. Cardi...
CardioCell : Overview
http://stemcardiocell.com/clinical-trials/overview
Exclusive Stem Cell License. CardioCell is currently exploring clinical studies for:. Acute Myocardial Infarction (AMI). Chronic Heart Failure (CHF). Peripheral Artery Disease (PAD). Exclusive Stem Cell License. 1858875.6569 Fax: 1.858.746.5185. 5375 Mira Sorrento Place, Ste. 260. San Diego, CA 92121.
CardioCell : Scientific Advisory Board
http://stemcardiocell.com/about-us/scientific-advisory-board
Exclusive Stem Cell License. Exclusive Stem Cell License. Stephen E. Epstein, M.D. Director, Translational and Vascular Biology Research, MedStar Heart Institute, MedStar Washington Hospital Center. Clinical Professor of Medicine, Georgetown University. Javed Butler, M.D., MPH, FACC, FAHA. Chief of the Cardiology Division, Stony Brook Heart Institute. Mihai Gheorghiade, M.D., FACC. Professor of Medicine and Surgery, Associate Director, Director of Experimental Therapeutics, Center for Cardiovascular Inno...
CardioCell : Exclusive Stem Cell License
http://stemcardiocell.com/about-us/our-parent-company
Exclusive Stem Cell License. Exclusive Stem Cell License. Exclusive Stem Cell License. Established in 2013, CardioCell has an exclusive, worldwide Stemedica Cell Technologies Inc. license for the exploration of therapeutic indications in the cardiovascular field. Stemedica continues its focus on stem-cell manufacturing technology, scale-up manufacturing and other related activities, while CardioCell explores cardiovascular applications for these stem cells. In addition to its manufacturing capabilities, ...
CardioCell : Press Releases
http://stemcardiocell.com/category/news/press-releases
Exclusive Stem Cell License. Monday, August 29, 2016. European Society of Cardiology (ESC) Congress Presentation Reveals Results From Pre-Clinical Study Using CardioCell’s Stem Cells for Acute Myocardial Infarction (AMI). Sunday, August 28, 2016. CardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells for Chronic Heart Failure Indications. European Society of Cardiology (ESC) Congress Poster Session Reveals Results From Pre-Clinical Study Using Ca...
TOTAL PAGES IN THIS WEBSITE
14
Stemedica News: February 2014
http://stemedica.blogspot.com/2014_02_01_archive.html
Tuesday, February 18, 2014. STEMEDICA ISSUED U.S. PATENT METHOD FOR IDENTIFYING NEURIPOTENT CELLS. Source: Feburary 18; Stemedica Cell Technologies, Inc.). Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors, announced today that the Company has been issued Patent No. US 8,642,286 B2 entitled, Methods for Identifying Neuripotent Cells. By the United States Patent and Trademark Office. Multi-lineage differentiation of human neural stem cells would...
stemedica | Stemedica's Blog
https://stemedica.wordpress.com/author/stemedica
Research, Pre-Clinical Trails (USA) using adult stem cells. Laquo; Older Entries. PRESIDENT OF LEADING SOUTH KOREAN BIOPHARMACEUTICAL COMPANY GREEN CROSS HOLDINGS JOINS STEMEDICA’S BOARD OF DIRECTORS. April 22, 2014. Source: April 22; San Diego). President Green Cross Holdings. Green Cross is the largest biopharmaceutical company in Korea. Green Cross provides safe and effective healthcare solutions that address the evolving needs of human health. Headquartered in Yongin, South Korea, Green Cross...STEME...
NEW PHASE IIA TRIAL IN THE UNITED STATES AND PHASE III TRIAL IN KAZAKHSTAN STUDY THE USE OF CARDIOCELL’S ITMSC THERAPY FOR TREATING ACUTE MYOCARDIAL INFARCTION | Stemedica's Blog
https://stemedica.wordpress.com/2014/02/17/new-phase-iia-trial-in-the-united-states-and-phase-iii-trial-in-kazakhstan-study-the-use-of-cardiocells-itmsc-therapy-for-treating-acute-myocardial-infarction
Research, Pre-Clinical Trails (USA) using adult stem cells. Laquo; STEMEDICA ANNOUNCES NEW BOARD MEMBER AND CHAIRMAN OF AUDIT COMMITTEE. STEMEDICA ISSUED U.S. PATENT METHOD FOR IDENTIFYING NEURIPOTENT CELLS. NEW PHASE IIA TRIAL IN THE UNITED STATES AND PHASE III TRIAL IN KAZAKHSTAN STUDY THE USE OF CARDIOCELL’S ITMSC THERAPY FOR TREATING ACUTE MYOCARDIAL INFARCTION. The Only AMI Clinical Trials Using Ischemia-Tolerant Mysenchymal Stem Cells (itMSCs) Enter Next Phase Based on Successful Previous Studies.
TOTAL LINKS TO THIS WEBSITE
5
Stem Capital
1 (855) 783-7836 client@stemcapital.com. We believe what we can do together will give others the opportunity to live their greatest life imaginable. We believe that we can do together will give others the opportunity to live their greatest life imaginable. Both as individuals within our organization and as an organization, Stem is committed to lending ongoing support to the following organizations. CEO, Stem Capital. Learn more about us. MaRS is where science, technology and social entrepreneurs get the ...
STEM Capital Partners
Stem Capital Partners is a Hong Kong based private investment firm focused on mid-cap companies in Asia Pacific. A central part of something from which other parts grow;. A fundamental line from which others have arisen;.
StemCaptain
Saturday, November 14, 2009. Compass Ready Thansgiving Weekend (I hope! It taken awhile I know. Thank you all for your feedback, support and requests for a compass over the last couple of years. It should be up for sale on my website. Stop by the site after you stuff down some turkey (or tofurkey) - StemCaptain makes a great stocking stuffer or gift exchange present. I will be offering free shipping for orders placed between Thurs. Nov. 26th and Dec 21st. Cheers, StemCaptain. Sunday, May 24, 2009. In Ft ...
Stem CAPtain
T and C s. REPLACE YOUR BORING NON-FUNCTIONAL STEM CAP. With a quality , durable fully functional Clock, Thermometer or Compass, giving an interesting feature as you ride. StemCAPtain, acccessories replace the boring normal, non-functional threadless style stem cap with an analog fully functional clock,compass, thermometer, picture frame or bottle opener. StemCAPtains are very easy to install. (click the "Installation"link above for a demo). And I will assist. Thanks. Results 1 - 7 of 7.
StemCAPtain
StemCAPtain is a Boulder, CO USA based bicycle accessory company. Our flagship product is the Original StemCAPtain Stem Cap Bike Clock. The StemCAPtain replaces the stem cap, aka top cap, piece of a threadless 1" or 1 1/8" headset with different functional accessories. In addition to the simple and elegant analog clock. We offer a thermometer. Very easy to install. And can be up and running on your bike in just a few ticks. Blazing heat or freezing cold, the thermometer provides a cool look and function.
CardioCell : Breakthrough Cardiovascular Therapy
Breakthrough cardiovascular therapy derived from allogeneic adult stem cells. Applying stem cell technology for cardiovascular indications is not just an idea anymore. CardioCell is currently in clinical trials using stem cells to develop highly effective, off-the-shelf therapeutic products for cardiovascular indication. These treatments will address the high, unmet medical needs in:. Acute Myocardial Infarction (AMI). Chronic Heart Failure (CHF). Peripheral Artery Disease (PAD). The initiation of a phas...
stemcare.com
This is a free Starter Web Page courtesy of GoDaddy. San Francisco, CA 94107. Confessions By My Angel. Free Download of the story, "Confessions. Click here to download PDF file. Email us at: mitch@jcsadv.com. Visit us at: http:/ myangelsconfessions.blogspot.com. Find a domain name:. Plus ICANN fee of 18 cents per domain name year.
Beskyt dit barns stamceller i Danmarks eneste Stamcellebank | StemCare
KORT OM STEMCARE A/S. KORT OM STEMCARE A/S. KORT OM STEMCARE A/S. KR/MD i 23 MD. Den bedste start på livet. 5 gode grunde til at beskytte dit barn. Hvilke sygdomme behandles i dag. Derfor beskytter vi vores børn. Sådan gør du – trin for trin. Tak for din interesse. 5 gode grunde til at passe på dine børns stamceller. Lær om stamceller – kroppens byggesten. Vores læger og personale svarer gerne på dine spørgsmål. Du kan også bestille en rundvisning, downloade eller bestille brochurer og materiale.
StemCare Foundation
8220;Although the world is full of sufferng, it is full aslo of the OVERCOMING of it.” - Helen Keller. We Derive Our Inspiration From. The very substance on which our. Foundation was created- the Stem Cell. Just as it functions to repair damaged cells and generate new cells, StemCare. Foundation, too, aspires to heal and regenerate damaged lives…. To bridge the gap between people affected by. Incurable medical conditions and their chance to live a better life. The Primary Problems Faced. 91 9920 200 400.
Bevara ditt barns stamceller i StemCare stamcellsbank
En bra start på livet. Till att bevara ditt barns stamceller. Vilka sjukdomar behandlas idag? Spara stamceller – steg för steg. 5 goda anledningar att bevara ditt barns stamceller. Lär dig mer om stamceller – kroppens byggstenar. Vill du veta mer? Våra läkare och personal svarar gärna på dina frågor så hör gärna av dig till oss. Du kan även boka rundvisning, ladda ner och beställa broschyrer och annat material. Titta på videon där Emma Smal berättar hennes berättelse här. Vi tar också emot.
Stem Career
Why STEM Centric Career Development? About Subscribe to Stem Career. Identify with a Scientist! Produce a Scientific Leader. April 3rd, 2017. Provides a great summary of some of the key insights into how to spot and develop individual’s talent for STEM careers. Your Kids Benefit from Your Full-Time Career. March 30th, 2017. Of Kathleen McGinn and colleagues’ research findings here. Equal Representation on the Horizon. March 27th, 2017. If you’re a woman interested in entering the field of technology, the...
